切除性肺腺癌中央型肿瘤位置:与复发及生存结局的相关性
本回顾性研究纳入1796例切除性浸润性肺腺癌患者,利用自动肺分割算法在CT上按两种参考点(肿瘤中心、肿瘤内侧缘)和四种定义判定中央型位置,评估其与局部区域复发、远处复发、无复发生存期(RFS)和总生存期(OS)的关联。结果显示,按定义1(肿瘤中心位于肺内1/3)和定义3(内侧缘位于内1/3)判定的中央型位置与局部区域复发风险升高、RFS更差独立相关,定义1还与OS更差独立相关;所有关联在病理I期亚组中同样存在。作者认为中央型位置患者可能需要更密切的术后监测。
要点
- 按肿瘤中心位于肺内1/3定义中央型时,局部区域复发风险升高(sHR=1.75,p=.004)、RFS更差(HR=1.52,p<.001)、OS更差(HR=1.45,p=.02)。
- 按肿瘤内侧缘位于肺内1/3定义中央型时,局部区域复发风险升高(sHR=1.44,p=.01)、RFS更差(HR=1.28,p=.003)。
- 四种中央型定义均与远处复发无独立关联。
核心结论
- 在切除性肺癌患者中,肿瘤中心位于肺内1/3所定义的中央型位置与局部区域复发风险升高及RFS、OS更差独立相关。
- 定义1和定义3的中央型位置与局部区域复发独立相关,四种定义均与远处复发无独立关联。
- 上述关联在病理I期亚组(1172例)中同样观察到。
研究设计与样本
- 回顾性研究,纳入2010年7月至2019年12月间因浸润性肺腺癌行肺叶切除或全肺切除的患者1796例(男849例、女947例,平均年龄62.7岁)。
- 开发自动算法(https://github.com/provbs/L3P_rb)生成分割掩膜,将CT上的肺分为三个同心区域;放射科医师借助掩膜,基于肿瘤中心和肿瘤内侧缘两个参考点,将每例肿瘤分为位于肺内1/3、中1/3或外1/3。
- 按四种定义判定中央型与周围型:定义1(中心位于内1/3)、定义2(中心位于内2/3)、定义3(内侧缘位于内1/3)、定义4(内侧缘位于内2/3)。
- 评估中央型位置与局部区域复发、远处复发、RFS和OS的关联,并校正影响肺癌生存的协变量,包括病理淋巴结分期。
诊断标准与关键数值
- 定义1判定为中央型的患者147例(8.2%),定义2为916例(51.0%),定义3为521例(29.0%),定义4为1427例(79.4%)。
- 定义1中央型与局部区域复发独立相关(sHR=1.75,p=.004),定义3中央型与局部区域复发独立相关(sHR=1.44,p=.01)。
- 定义1中央型与RFS更差独立相关(HR=1.52,p<.001),定义3中央型与RFS更差独立相关(HR=1.28,p=.003)。
- 定义1中央型与OS更差独立相关(HR=1.45,p=.02)。
- 四种定义均与远处复发无独立关联。
临床应用与阅片要点
- 作者指出,中央型肺癌患者可能需要更密切的术后监测。
- 按肿瘤中心位于肺内1/3(定义1)判定中央型时,与局部区域复发、RFS和OS的关联最明显;按肿瘤内侧缘位于肺内1/3(定义3)判定时与局部区域复发和RFS相关。
- 四种中央型定义均未显示与远处复发的独立关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Prognostic implications of lung cancer location remain uncertain, in part relating to heterogeneous definitions for central tumor location. OBJECTIVE. The purpose of this study was to assess associations of central tumor location, determined using an automated lung segmentation algorithm, with recurrence and survival outcomes for patients with resected lung adenocarcinoma. METHODS. This retrospective study included patients who underwent lobectomy or pneumonectomy for invasive lung adenocarcinoma between July 2010 and December 2019. An automated algorithm (https://github.com/provbs/L3P_rb) was developed to generate segmentation masks dividing the lungs on CT into three concentric regions. Radiologists reviewed preoperative chest CT examinations using these masks to classify each tumor as being located in the inner, middle, or outer third of the lung based on each of two reference points (tumor center and tumor medial margin). Each tumor was then classified as central versus peripheral in location according to four definitions: center within inner one-third (definition 1), center within inner two-thirds (definition 2), medial margin within inner one-third (definition 3), or medial margin within inner two-thirds (definition 4). Associations of central location with locoregional and distant recurrences, recurrence-free survival (RFS), and overall survival (OS) were evaluated, adjusting for covariates influencing lung cancer survival, including pathologic nodal category. RESULTS. Among 1796 patients (849 men and 947 women; mean age, 62.7 years), 147 (8.2%), 916 (51.0%), 521 (29.0%), and 1427 (79.4%) were classified as having central tumors according to definitions 1, 2, 3, and 4, respectively. Central location showed independent associations with increased risk of locoregional recurrence for definition 1 (subdistribution hazard ratio [sHR] = 1.75; p = .004) and definition 3 (sHR = 1.44; p = .01); no definition was independently associated with distant recurrence. Central location showed independent associations with worse RFS for definition 1 (HR = 1.52; p < .001) and definition 3 (HR = 1.28; p = .003) and with worse OS for definition 1 (HR = 1.45; p = .02). All of these associations were also observed in a subset of 1172 patients with pathologic stage I disease. CONCLUSION. In patients with resected lung cancer, central location, defined as location of the tumor center within the inner one-third of the lung, was independently associated with increased risk of locoregional recurrence and poorer RFS and OS. CLINICAL IMPACT. Patients with centrally located lung cancers may warrant closer postoperative surveillance.
引用
- Ahn Y, Lee SM, Kim Y, et al. Central Tumor Location in Resected Lung Adenocarcinoma: Association With Recurrence and Survival Outcomes. AJR Am J Roentgenol. 2026. PMID: 40864987. doi:10.2214/AJR.25.33503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。